Send the following on WhatsApp
Continue to ChatLucentis*, ranibizumab, nouvelle indication ophtalmique aux USA https://www.pharmacorama.com/2012/08/lucentis-ranibizumab-nouvelle-indication-ophtalmique-usa/
Lucentis*, ranibizumab, nouvelle indication ophtalmique aux USA https://www.pharmacorama.com/2012/08/lucentis-ranibizumab-nouvelle-indication-ophtalmique-usa/